Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study.
Adams D, Polydefkis M, González-Duarte A, Wixner J, Kristen AV, Schmidt HH, Berk JL, Losada López IA, Dispenzieri A, Quan D, Conceição IM, Slama MS, Gillmore JD, Kyriakides T, Ajroud-Driss S, Waddington-Cruz M, Mezei MM, Planté-Bordeneuve V, Attarian S, Mauricio E, Brannagan TH 3rd, Ueda M, Aldinc E, Wang JJ, White MT, Vest J, Berber E, Sweetser MT, Coelho T; patisiran Global OLE study group. Adams D, et al. Among authors: losada lopez ia. Lancet Neurol. 2021 Jan;20(1):49-59. doi: 10.1016/S1474-4422(20)30368-9. Epub 2020 Nov 16. Lancet Neurol. 2021. PMID: 33212063 Clinical Trial.
[IgG4-related disease].
González-Moreno J, Losada López I, Ortego Centeno N. González-Moreno J, et al. Med Clin (Barc). 2015 Dec 21;145(12):539-44. doi: 10.1016/j.medcli.2014.12.017. Epub 2015 Feb 25. Med Clin (Barc). 2015. PMID: 25726306 Review. Spanish.
Amyloidotic breast nodule in hereditary transthyretin amyloidosis (hATTR): a case report.
Cisneros-Barroso E, Losada-López I, González-Moreno J, Buades J, Ferrer-Nadal A, Ripoll-Vera T, Usón M, Figuerola A, Montalà JC, Descals C, Salva-Ramonell F, Torres-Rovira J, Gene-Heym A, Fernández-Burgos I, Soler T. Cisneros-Barroso E, et al. Amyloid. 2019;26(sup1):59-60. doi: 10.1080/13506129.2019.1582521. Amyloid. 2019. PMID: 31343326 No abstract available.
Association between aortic stenosis and hereditary transthyretin amyloidosis.
Ripoll-Vera T, Álvarez Rubio J, Iglesias M, Losada López I, Ferrer-Nadal A, González Moreno J. Ripoll-Vera T, et al. Rev Esp Cardiol (Engl Ed). 2021 Feb;74(2):185-187. doi: 10.1016/j.rec.2020.05.037. Epub 2020 Aug 7. Rev Esp Cardiol (Engl Ed). 2021. PMID: 32778403 English, Spanish. No abstract available.
Follow-up regimens for carriers of hereditary transthyretin variants.
Losada-López IA, Kapetanovic-García S, Sevilla-Mantecón T, Muñoz-Beamud F. Losada-López IA, et al. Med Clin (Barc). 2023 Mar 10;160(5):213-217. doi: 10.1016/j.medcli.2022.10.002. Epub 2022 Dec 16. Med Clin (Barc). 2023. PMID: 36529555 English, Spanish. No abstract available.
Disease risk estimates in V30M variant transthyretin amyloidosis (A-ATTRv) from Mallorca.
Cisneros-Barroso E, Gorram F, Ribot-Sansó MA, Alarcon F, Nuel G, González-Moreno J, Rodríguez A, Hernandez-Rodriguez J, Amengual-Cladera E, Martínez-López I, Ripoll-Vera T, Losada-López I, Heine-Suñer D, Plante-Bordeneuve V. Cisneros-Barroso E, et al. Orphanet J Rare Dis. 2023 Aug 31;18(1):255. doi: 10.1186/s13023-023-02865-5. Orphanet J Rare Dis. 2023. PMID: 37653545 Free PMC article.
20 results